As a service to the global R&D community, Science|Business has compiled this database of funding opportunities. Users are encouraged to let us know of funding calls that could be incorporated into the database. Please email all suggestions to [email protected]. The database will be updated daily. For rapid news about COVID-19, see our live blog.
Projects should carry out on rapid research into fundamental virology, immunology, and the development of animal models, reagents, and medical countermeasures.
Amount
Up to $275.000 (USD)
Agency or Funder
National Institute of Allergy and Infectious Diseases (NIAID)
This call aims to strengthen the evidence base to better prevent and control coronavirus (COVID-19) epidemics and to increase research and response capacity.
Amount
Up to £2M
Agency or Funder
Wellcome Trust & UK Department for International Development (DFID)
Eligibility (if available)
PhD plus significant postdoctoral experience in an academic research organisation, a not-for-profit or government body, a private sector organisation
Innovation Fund Denmark is seeking interdisciplinary projects to mitigate the impact of the outbreak on citizens, the healthcare system or the social economy through diagnosis, management and/or treatment.
The Ministry of Science, Technology and Innovation is looking for scientific and technological solutions related to diagnosis, treatment , mitigation and monitoring.
Amount
COP$ 26M
Agency or Funder
Ministry of Science, Technology and Innovation of Colombia
A wide-ranging opportunity for projects related to – among others – diagnostic tools, use of big data analysis, robotic devices, virology, co-infection and social media to manage COVID-19.
A call for novel therapies, broad-spectrum antivirals, next-generation vaccines that may target new corona strains, multiple corona viruses or more than one type of virus, and strategies for first responders and emergency medical personnel.
Amount
$150.000 (U.S.) guaranteed, with the potential to receive up to $1 million
Agency or Funder
Harrington Discovery Institute
Eligibility (if available)
Project lead must have an MD, PhD or equivalent and based in the U.S., UK or Canada.
Submission of applications for assistance with R&D and technological innovation plans. The final date for applications is 18 May, but there are multiple submission dates before that time: 30 March, 20 April, and 4 May.
Amount
30% to 70% of approved R&D expenses
Agency or Funder
Israel Innovation Authority
Eligibility (if available)
Companies in the manufacturing industry in a variety of fields
A £10 million fund to support research to accelerate the development and testing of therapeutics that can be rapidly deployed to treat the symptoms of COVID-19.
Amount
£10M
Agency or Funder
LifeArc
Eligibility (if available)
Academics, NHS employees or companies that have therapeutics that could be repurposed or repositioned for use in COVID-19 patients
Proposals sought for a clinical trial that accelerates the implementation of treatments for severe acute respiratory distress in patients infected with COVID-19 in order to support the response to the COVID-19 outbreak in Australia.
Amount
$5M AUD
Agency or Funder
Australian National Health and Medical Research Council (NHMRC)
Eligibility (if available)
Applications will only be accepted from NHMRC approved Administering Institutions
Funding for clinical trials to evaluate new drugs, devices, clinical guidance, approaches and technologies aimed at stopping the spread of COVID-19. Projects may range from proof-of-concept to large-scale trials.
Amount
$30M (U.S.)
Agency or Funder
US Army Medical Research Acquisition Activity
Eligibility (if available)
Principal investigator must be at level of Assistant Professor or equivalent.
Competitive revisions to active grants in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeut
Amount
Not limited
Agency or Funder
U.S. National Institutes of Health (NIH) - NIAID & NIGMS
Eligibility (if available)
Existing grantholders wishing to expand the scope of their research.